Shire secures US nod for once-daily ADHD drug
Pharma times | June 22, 2017
The drug, which was first submitted in the country back in 2006, has the same active ingredient as the firm's Adderall XR (mixed amphetamine salts), but is designed to provide symptom control for adults with ADHD for up to 16 hours as opposed to the 12 to 14 hours currently offered by alternative treatments.